For the Media
Dr. Gary Lyman is member of Fred Hutch's Public Health Sciences and Clinical Research Division. He is an oncologist and health economist. Dr. Lyman is co-director of the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred Hutch helping patients and providers determine the true value of cancer care.
Overview of Gary Lyman's clinical/research focus
Dr. Lyman is practicing medical oncologist and is nationally and internationally recognized for his leadership in comparative effectiveness, health services and outcomes research. He has appointments at Fred Hutch and the University of Washington.
Gary Lyman - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
Public Health Sciences Division
Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place.
Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.